AIP
AVBP icon

Ameritas Investment Partners’s ArriVent BioPharma AVBP Stock Holding History

Ameritas Investment Partners’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Buy
3,441
+1,089
+46% +$32.1K ﹤0.01% 1718
2026
Q1 		$54.3K Hold
2,352
– – ﹤0.01% 2040
2025
Q4 		$47.3K Hold
2,352
– – ﹤0.01% 2164
2025
Q3 		$43.4K Hold
2,352
– – ﹤0.01% 2232
2025
Q2 		$51.2K Sell
2,352
-502
-18% -$10.4K ﹤0.01% 2172
2025
Q1 		$52.8K Hold
2,854
– – ﹤0.01% 2073
2024
Q4 		$76K Hold
2,854
– – ﹤0.01% 1943
2024
Q3 		$67.1K Buy
2,854
+1,873
+191% +$42.5K ﹤0.01% 2022
2024
Q2 		$18.2K Hold
981
– – ﹤0.01% 2661
2024
Q1 		$17.5K Buy
+981
New +$19.8K ﹤0.01% 2609

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameritas Investment Partners's AVBP Position: Q2 2026 in Review

Ameritas Investment Partners increased its ArriVent BioPharma (AVBP) stake by 46% in Q2 2026, buying an estimated $32.1K and bringing the position to 3,441 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Ameritas Investment Partners first reported a position in AVBP in Q1 2024 and has held it in 10 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Ameritas Investment Partners held 3,441 shares of ArriVent BioPharma worth $120K as of Q2 2026.
  • Ameritas Investment Partners bought 1,089 ArriVent BioPharma shares in Q2 2026, an estimated $32.1K.
  • ArriVent BioPharma made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1718 holding.
  • Ameritas Investment Partners first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 10 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.